JPH11180869A5 - - Google Patents

Info

Publication number
JPH11180869A5
JPH11180869A5 JP1997363266A JP36326697A JPH11180869A5 JP H11180869 A5 JPH11180869 A5 JP H11180869A5 JP 1997363266 A JP1997363266 A JP 1997363266A JP 36326697 A JP36326697 A JP 36326697A JP H11180869 A5 JPH11180869 A5 JP H11180869A5
Authority
JP
Japan
Prior art keywords
bergenin
bergenia
agent
cyclic amp
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997363266A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11180869A (ja
JP4002654B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP36326697A priority Critical patent/JP4002654B2/ja
Priority claimed from JP36326697A external-priority patent/JP4002654B2/ja
Publication of JPH11180869A publication Critical patent/JPH11180869A/ja
Publication of JPH11180869A5 publication Critical patent/JPH11180869A5/ja
Application granted granted Critical
Publication of JP4002654B2 publication Critical patent/JP4002654B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP36326697A 1997-12-16 1997-12-16 血中脂質改善剤、サイクリックａｍｐホスホジエステラーゼ阻害剤、及び肥満の予防・解消剤、並びに飲食品及び皮膚外用剤 Expired - Fee Related JP4002654B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP36326697A JP4002654B2 (ja) 1997-12-16 1997-12-16 血中脂質改善剤、サイクリックａｍｐホスホジエステラーゼ阻害剤、及び肥満の予防・解消剤、並びに飲食品及び皮膚外用剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP36326697A JP4002654B2 (ja) 1997-12-16 1997-12-16 血中脂質改善剤、サイクリックａｍｐホスホジエステラーゼ阻害剤、及び肥満の予防・解消剤、並びに飲食品及び皮膚外用剤

Publications (3)

Publication Number Publication Date
JPH11180869A JPH11180869A (ja) 1999-07-06
JPH11180869A5 true JPH11180869A5 (https=) 2004-10-21
JP4002654B2 JP4002654B2 (ja) 2007-11-07

Family

ID=18478910

Family Applications (1)

Application Number Title Priority Date Filing Date
JP36326697A Expired - Fee Related JP4002654B2 (ja) 1997-12-16 1997-12-16 血中脂質改善剤、サイクリックａｍｐホスホジエステラーゼ阻害剤、及び肥満の予防・解消剤、並びに飲食品及び皮膚外用剤

Country Status (1)

Country Link
JP (1) JP4002654B2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4310567B2 (ja) * 2001-11-10 2009-08-12 ビーエイチエヌ株式会社 血中脂質改善剤
US6531162B1 (en) * 2002-07-30 2003-03-11 William Charles Llewellyn Adrenergically-mediated weight loss product
KR100544034B1 (ko) * 2004-01-12 2006-01-23 주식회사 코리아나화장품 베르게닌을 함유하는 노화 방지용 화장료 조성물
JP5265282B2 (ja) * 2008-09-19 2013-08-14 花王株式会社 皮膚化粧料
JP5265283B2 (ja) * 2008-09-25 2013-08-14 花王株式会社 皮膚化粧料
JP2009102419A (ja) * 2009-02-04 2009-05-14 Bhn Kk 血中コレステロール低減剤
JP5926507B2 (ja) * 2011-06-23 2016-05-25 バイオランド・リミテッド マトリックスメタロプロテアーゼ阻害剤の製造方法、エラスターゼ阻害剤の製造方法、ヒアルロニダーゼ阻害剤の製造方法及びシワ防止用皮膚外用剤の製造方法
JP6066603B2 (ja) * 2012-07-13 2017-01-25 小林製薬株式会社 Ｄｐｐ４阻害剤
JP6362127B2 (ja) * 2013-03-22 2018-07-25 島根県 アカメガシワ葉加工物を含有するコレステロール低下剤
JP5863721B2 (ja) * 2013-07-24 2016-02-17 丸善製薬株式会社 肥満解消剤、脂肪分解促進剤、サイクリックａｍｐ−ホスホジエステラーゼ活性阻害剤、及びラット副睾丸脂肪細胞の脂肪分解促進剤
CN105037382B (zh) * 2015-07-07 2017-08-25 中国药科大学 岩白菜素类衍生物及其制备方法和应用
JP6981641B2 (ja) * 2017-03-16 2021-12-15 ビーエイチエヌ株式会社 Ｐｄｅ５活性阻害剤

Similar Documents

Publication Publication Date Title
JPH11180869A5 (https=)
US4496548A (en) Composition and method for reducing hangover
CZ295869B6 (cs) Kompozice s antimikrobiálním účinkem a její použití k přípravě farmaceutického prostředku pro léčení infekčních onemocnění
FI4337632T3 (fi) Resorsinolijohdannainen farmaseuttisesti vaikuttavana yhdisteenä ja sen valmistusmenetelmä
EP1283054A4 (en) MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF
WO2005030753A3 (en) Therapeutic agents useful for treating pain
US5977184A (en) Quercetin chalcone and methods related thereto
JP4097294B2 (ja) 神経障害性疼痛の処置に有用の鎮痙性誘導体
DE69727836D1 (de) Darmentzündungen vorbeugendes und therapeutisches arzneimittel
WO1998006265A3 (en) Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine
TNSN00034A1 (fr) Derives de 2-aminopyridine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
WO1999048501A9 (fr) Voacamine en tant qu'agent anti-paludeen et agent anti-paludeen contenant de la voacamine
CA2438509A1 (en) Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
WO2001081328A3 (en) Thiazolidinedione analogues and their use for the treatment of diabetes
EP0722325B1 (fr) Composition pour le traitement ou la prevention de l'herpes
CN113876629A (zh) 一种免洗洗手液及其制备方法
WO2023204602A1 (ko) 복합한약재 추출물을 유효성분으로 포함하는 코로나바이러스 감염증의 예방, 개선 또는 치료용 조성물
EP0762876A1 (en) A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof
RU2184534C2 (ru) Антисептические таблетки
JPH11199504A5 (https=)
US4386105A (en) Use of alpha, alpha-dialkyl adamantylethylamines to treat measles
WO2001097778A8 (en) Amphotericin b structured emulsion
JPH0680576A (ja) ヒアルロニダーゼ阻害剤
JPS5899414A (ja) アルド−スレダクタ−ゼの阻害剤
CA2383755A1 (en) Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same